Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Nippon Kayaku Prevails in Elplat Damage Suit: High Court
June 30, 2017
- Takeda Files Teva’s Parkinson’s Disease Med in Japan
June 30, 2017
- Weber’s FY2016 Pay Tops 1 Billion Yen: Takeda Securities Filing
June 30, 2017
- Oncolys to Initiate PI Trial of Oncolytic Virus Telomelysin “Shortly” in Japan
June 30, 2017
- Takeda Chairman Hasegawa Officially Steps Aside as Adviser
June 29, 2017
- Eisai Temporarily Rescinds NDA for Halaven in China due to Request for Additional Data
June 29, 2017
- Adcetris Hits Primary Endpoint in PIII Trial for Frontline Advanced Hodgkin’s Lymphoma: Takeda, Seattle Genetics
June 29, 2017
- AbbVie Japan Set to Build Up Organization to Gear Up for Oncology Drug Launches: President
June 28, 2017
- Drug Makers Moving to Outsource “Pharmaceutical Scouting” to Seek Efficiency: Ex-Sanofi Exec
June 28, 2017
- Stivarga OK’ed for 2nd-Line HCC, Oldamin for Gastric Varices, Actemra for Shorter Dose Interval
June 27, 2017
- Takeda in Technology Licensing Deals with Biological E. for Low-Cost Vaccines
June 27, 2017
- Immuno-Biological Laboratories, TransGenic Collaborate on AD Drug Research
June 27, 2017
- Keytruda Earns Priority Review Status for Urothelial Cancer
June 27, 2017
- Pfizer Japan Oncology Unit Creates Growth Strategy, Portfolio Priority Map to Gear Up for Doubling of Products
June 27, 2017
- Pfizer Japan Ups Oncology Sales Force, Reorganizes It into Blood, Solid Cancer Groups
June 27, 2017
- Unauthorized Additive Used for Yamamoto Chemical’s Zonisamide
June 27, 2017
- Sumitomo Dainippon’s Napabucasin Stumbles on PIII Gastric Cancer Study
June 27, 2017
- Fujifilm, CanBas Pair Up for Joint Research on Peptide-Based Cancer Immunotherapies
June 27, 2017
- Daiichi Sankyo Confident of Achieving US$1 Billion Sales for Edoxaban
June 26, 2017
- FDA Snubs Takeda/Lundbeck’s Reattempt for Trintellix Label Expansion
June 26, 2017
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…